Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Jazz Pharmaceuticals Plc (JAZZ) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Jazz Pharmaceuticals Plc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1232524.
Total stock buying since 2015: $24,695,433.
Total stock sales since 2015: $175,721,274.
Total stock option exercises since 2015: $23,063,639.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 101,621 | $10,057,861 | 41,509 | $5,600,607 | 4,813 | $569,040 |
2024 | 12,000 | $1,435,800 | 17,030 | $1,972,531 | 0 | $0 |
2023 | 0 | $0 | 48,698 | $6,931,426 | 12,830 | $966,649 |
2022 | 0 | $0 | 178,819 | $26,449,201 | 175,375 | $10,471,706 |
2021 | 0 | $0 | 75,994 | $11,710,301 | 31,752 | $1,486,946 |
2020 | 50,000 | $5,544,330 | 67,130 | $9,668,125 | 56,264 | $882,841 |
2019 | 0 | $0 | 53,277 | $7,548,736 | 8,333 | $517,809 |
2018 | 50,000 | $7,179,700 | 87,026 | $14,370,940 | 27,425 | $2,435,236 |
2017 | 0 | $0 | 92,629 | $13,736,901 | 82,862 | $3,685,505 |
2016 | 3,745 | $477,742 | 125,690 | $16,966,269 | 0 | $0 |
2015 | 0 | $0 | 359,569 | $60,766,237 | 43,113 | $2,047,907 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2017-08-14 | Treacy Paul (SVP, Technical Operations) | Sale | 1,304 | 143.35 | 186,932 |
2017-08-11 | Schnee Elmar (Director) | Sale | 1,199 | 143.56 | 172,132 |
2017-08-11 | Gray Peter (Director) | Sale | 717 | 143.29 | 102,738 |
2017-08-11 | Mcsharry Heather Ann (Director) | Sale | 717 | 143.24 | 102,705 |
2017-08-11 | Sohn Catherine A. (Director) | Sale | 662 | 143.29 | 94,857 |
2017-08-11 | O'keefe Kenneth W (Director) | Sale | 662 | 143.24 | 94,822 |
2017-08-11 | Winningham Rick E (Director) | Sale | 662 | 143.29 | 94,857 |
2017-08-11 | Enright Patrick G (Director) | Sale | 662 | 143.25 | 94,828 |
2017-08-11 | Berns Paul L (Director) | Sale | 662 | 143.25 | 94,828 |
2017-08-11 | Riedel Norbert G (Director) | Sale | 662 | 143.25 | 94,828 |
2017-07-20 | Hooper Suzanne Sawochka (EVP & General Counsel) | Sale | 4,580 | 160.00 | 732,800 |
2017-07-17 | Miller Michael Patrick (EVP, US Commercial) | Sale | 200 | 154.97 | 30,994 |
2017-06-23 | Hooper Suzanne Sawochka (EVP & General Counsel) | Sale | 420 | 160.00 | 67,200 |
2017-06-15 | Miller Michael Patrick (EVP, US Commercial) | Sale | 200 | 150.65 | 30,130 |
2017-06-01 | Winningham Rick E (Director) | Sale | 5,000 | 150.00 | 750,000 |
2017-05-11 | Cozadd Bruce C (Chairman & CEO) | Sale | 30,000 | 153.42 | 4,602,660 |
2017-05-09 | Hooper Suzanne Sawochka (EVP & General Counsel) | Sale | 2,500 | 160.00 | 400,000 |
2017-04-27 | Hooper Suzanne Sawochka (EVP & General Counsel) | Sale | 2,500 | 160.00 | 400,000 |
2017-04-27 | Wilson Karen J (SVP, Finance & PAO) | Sale | 1,275 | 160.00 | 204,000 |
2017-04-17 | Miller Michael Patrick (SVP, US Commercial) | Sale | 200 | 152.56 | 30,512 |
2017-04-11 | Cozadd Bruce C (Chairman & CEO) | Sale | 1,000 | 152.12 | 152,120 |
2017-04-10 | Wilson Karen J (SVP, Finance & PAO) | Sale | 11,458 | 152.24 | 1,744,365 |
2017-04-10 | Wilson Karen J (SVP, Finance & PAO) | Option Ex | 11,458 | 52.98 | 607,044 |
2017-03-15 | Miller Michael Patrick (SVP, US Commercial) | Sale | 200 | 137.89 | 27,577 |
2017-03-08 | Wilson Karen J (SVP, Finance & PAO) | Option Ex | 3,646 | 52.98 | 193,165 |
2017-03-06 | Treacy Paul (SVP, Technical Operations) | Sale | 884 | 131.97 | 116,665 |
2017-01-18 | Cox Russell J. (EVP & COO) | Sale | 4,000 | 127.50 | 510,000 |
2017-01-17 | Miller Michael Patrick (SVP, US Commercial) | Sale | 200 | 115.93 | 23,186 |
2016-12-15 | Miller Michael Patrick (SVP, US Commercial) | Sale | 200 | 103.09 | 20,618 |
2016-12-02 | Enright Patrick G (Director) | Sale | 1,354 | 101.80 | 137,836 |
2016-11-15 | Miller Michael Patrick (SVP, US Commercial) | Sale | 200 | 112.19 | 22,438 |
2016-11-14 | O'keefe Kenneth W (Director) | Buy | 500 | 112.45 | 56,223 |
2016-11-11 | O'keefe Kenneth W (Director) | Buy | 1,500 | 114.32 | 171,475 |
2016-10-17 | Miller Michael Patrick (SVP, US Commercial) | Sale | 200 | 118.16 | 23,632 |
2016-09-19 | Miller Michael Patrick (SVP, US Commercial) | Sale | 200 | 126.17 | 25,234 |
2016-08-25 | Mulligan Seamus (Director) | Sale | 27,968 | 128.19 | 3,585,078 |
2016-08-16 | Treacy Paul (SVP, Technical Operations) | Sale | 1,292 | 137.46 | 177,603 |
2016-08-15 | Mcsharry Heather Ann (Director) | Sale | 685 | 136.45 | 93,468 |
2016-08-15 | Sohn Catherine A. (Director) | Sale | 633 | 136.45 | 86,372 |
2016-08-15 | Winningham Rick E (Director) | Sale | 633 | 136.45 | 86,372 |
2016-08-15 | Enright Patrick G (Director) | Sale | 633 | 136.45 | 86,372 |
2016-08-15 | Miller Michael Patrick (SVP, US Commercial) | Sale | 100 | 136.45 | 13,644 |
2016-08-15 | Berns Paul L (Director) | Sale | 633 | 136.45 | 86,372 |
2016-08-15 | Riedel Norbert G (Director) | Sale | 633 | 136.45 | 86,372 |
2016-08-12 | Smith Karen L. (Global Head of R&D and CMO) | Buy | 608 | 137.18 | 83,406 |
2016-08-09 | Cox Russell J. (EVP & COO) | Sale | 4,000 | 148.66 | 594,640 |
2016-08-09 | Cozadd Bruce C (Chairman & CEO) | Sale | 1,000 | 150.00 | 150,000 |
2016-07-15 | Miller Michael Patrick (SVP, US Commercial) | Sale | 100 | 142.43 | 14,243 |
2016-07-13 | Smith Karen L. (Global Head of R&D and CMO) | Buy | 580 | 143.63 | 83,304 |
2016-06-15 | Miller Michael Patrick (SVP, US Commercial) | Sale | 100 | 149.64 | 14,963 |
2016-06-13 | Smith Karen L. (Global Head of R&D and CMO) | Buy | 557 | 149.61 | 83,334 |
2016-05-24 | Mulligan Seamus (Director) | Sale | 27,968 | 150.13 | 4,198,807 |
2016-05-16 | Mcsharry Heather Ann (Director) | Sale | 697 | 145.20 | 101,204 |
2016-05-16 | Miller Michael Patrick (SVP, US Commercial) | Sale | 100 | 145.20 | 14,519 |
2016-05-16 | Riedel Norbert G (Director) | Sale | 644 | 145.20 | 93,508 |
2016-04-25 | Wilson Karen J (SVP, Finance & PAO) | Sale | 604 | 160.00 | 96,640 |
2016-04-15 | Miller Michael Patrick (SVP, US Commercial) | Sale | 100 | 145.79 | 14,579 |
2016-04-13 | Wilson Karen J (SVP, Finance & PAO) | Sale | 5,007 | 150.00 | 751,050 |
2016-04-12 | Cox Russell J. (EVP & COO) | Sale | 4,000 | 136.98 | 547,920 |
2016-04-07 | Wilson Karen J (SVP, Finance & PAO) | Sale | 2,161 | 140.90 | 304,484 |
2016-03-15 | Miller Michael Patrick (SVP, US Commercial) | Sale | 100 | 129.17 | 12,916 |
2016-03-08 | Cozadd Bruce C (Chairman & CEO) | Sale | 2,500 | 126.04 | 315,100 |
2016-02-23 | Mulligan Seamus (Director) | Sale | 27,968 | 122.83 | 3,435,197 |
2016-01-15 | Miller Michael Patrick (SVP, US Commercial) | Sale | 100 | 122.66 | 12,266 |
2016-01-12 | Cozadd Bruce C (Chairman & CEO) | Sale | 2,500 | 123.81 | 309,525 |
2016-01-05 | Enright Patrick G (Director) | Sale | 10,000 | 138.44 | 1,384,379 |
2015-12-15 | Miller Michael Patrick (SVP, US Commercial) | Sale | 100 | 136.99 | 13,699 |
2015-12-08 | Cozadd Bruce C (Chairman & CEO) | Sale | 2,500 | 139.72 | 349,300 |
2015-12-02 | Enright Patrick G (Director) | Sale | 424 | 148.49 | 62,959 |
2015-12-01 | Enright Patrick G (Director) | Sale | 10,000 | 146.83 | 1,468,300 |
2015-11-23 | Mulligan Seamus (Director) | Sale | 10,243 | 147.65 | 1,512,419 |
2015-11-20 | Mulligan Seamus (Director) | Sale | 17,725 | 145.70 | 2,582,567 |
2015-11-16 | Miller Michael Patrick (SVP, US Commercial) | Sale | 100 | 134.03 | 13,403 |
2015-11-13 | Mcgill Iain (SVP, Europe & Rest of World) | Sale | 2,821 | 135.73 | 382,885 |
2015-11-10 | Enright Patrick G (Director) | Sale | 10,000 | 134.48 | 1,344,770 |
2015-11-10 | Cozadd Bruce C (Chairman & CEO) | Sale | 2,500 | 128.53 | 321,325 |
2015-10-21 | Hooper Suzanne Sawochka (EVP & General Counsel) | Sale | 2,000 | 125.00 | 250,006 |
2015-10-15 | Miller Michael Patrick (SVP, US Commercial) | Sale | 100 | 131.86 | 13,186 |
2015-10-13 | Cozadd Bruce C (Chairman and CEO) | Sale | 2,500 | 131.50 | 328,750 |
2015-10-05 | Enright Patrick G (Director) | Sale | 10,000 | 134.94 | 1,349,420 |
2015-09-25 | Miller Michael Patrick (SVP, US Commercial) | Sale | 100 | 145.23 | 14,522 |
2015-09-08 | Cozadd Bruce C (Chairman and CEO) | Sale | 2,500 | 163.44 | 408,587 |
2015-09-01 | Enright Patrick G (Director) | Sale | 10,000 | 166.36 | 1,663,560 |
2015-08-27 | Enright Patrick G (Director) | Sale | 425 | 167.87 | 71,344 |
2015-08-11 | Treacy Paul (SVP, Technical Operations) | Sale | 1,330 | 177.67 | 236,295 |
2015-08-11 | Sohn Catherine A. (Director) | Sale | 654 | 177.77 | 116,258 |
2015-08-11 | Hooper Suzanne Sawochka (EVP and General Counsel) | Sale | 4,000 | 177.82 | 711,280 |
2015-08-11 | Cox Russell J. (EVP & Chief Commercial Officer) | Sale | 500 | 177.82 | 88,910 |
2015-08-11 | Cozadd Bruce C (Chairman and CEO) | Sale | 2,500 | 177.82 | 444,550 |
2015-08-10 | Gray Peter (Director) | Sale | 867 | 182.02 | 157,812 |
2015-08-10 | Mcsharry Heather Ann (Director) | Sale | 867 | 181.15 | 157,052 |
2015-08-10 | Sohn Catherine A. (Director) | Sale | 801 | 182.02 | 145,798 |
2015-08-10 | Winningham Rick E (Director) | Sale | 801 | 181.67 | 145,518 |
2015-08-10 | Enright Patrick G (Director) | Sale | 10,801 | 181.97 | 1,965,511 |
2015-08-10 | Berns Paul L (Director) | Sale | 801 | 181.67 | 145,518 |
2015-08-10 | Riedel Norbert G (Director) | Sale | 801 | 181.67 | 145,517 |
2015-07-14 | Hooper Suzanne Sawochka (EVP & General Counsel) | Sale | 4,000 | 177.79 | 711,160 |
2015-07-14 | Hooper Suzanne Sawochka (EVP & General Counsel) | Option Ex | 4,000 | 46.83 | 187,320 |
2015-07-14 | Cozadd Bruce C (Chairman & CEO) | Sale | 5,000 | 177.79 | 888,950 |
2015-07-06 | Enright Patrick G (Director) | Sale | 10,000 | 177.25 | 1,772,490 |
2015-06-09 | Hooper Suzanne Sawochka (EVP & General Counsel) | Sale | 4,000 | 173.16 | 692,640 |
2015-06-09 | Hooper Suzanne Sawochka (EVP & General Counsel) | Option Ex | 4,000 | 46.83 | 187,320 |
2015-06-09 | Cozadd Bruce C (Chairman & CEO) | Sale | 5,000 | 173.16 | 865,800 |
2015-06-02 | Wilson Karen J (SVP, Finance & PAO) | Sale | 257 | 180.00 | 46,260 |
2015-06-01 | Wilson Karen J (SVP, Finance & PAO) | Sale | 5,494 | 179.62 | 986,859 |
2015-06-01 | Wilson Karen J (SVP, Finance & PAO) | Option Ex | 5,494 | 52.98 | 291,072 |
2015-06-01 | Enright Patrick G (Director) | Sale | 10,000 | 178.67 | 1,786,690 |
2015-05-26 | Mcgill Iain (SVP, Europe and Rest of World) | Sale | 7,334 | 179.48 | 1,316,328 |
2015-05-26 | Mcgill Iain (SVP, Europe and Rest of World) | Option Ex | 7,334 | 52.98 | 388,555 |
2015-05-12 | Gray Peter (Director) | Sale | 704 | 174.50 | 122,848 |
2015-05-12 | Hooper Suzanne Sawochka (EVP & General Counsel) | Sale | 4,000 | 173.85 | 695,400 |
2015-05-12 | Hooper Suzanne Sawochka (EVP & General Counsel) | Option Ex | 2,073 | 46.83 | 97,078 |
2015-05-12 | O'keefe Kenneth W (Director) | Sale | 1,218 | 174.90 | 213,025 |
2015-05-12 | O'keefe Kenneth W (Director) | Option Ex | 4,500 | 46.83 | 210,735 |
2015-05-12 | Cozadd Bruce C (Chairman & CEO) | Sale | 5,000 | 173.85 | 869,250 |
2015-05-12 | Riedel Norbert G (Director) | Sale | 650 | 174.47 | 113,408 |
2015-05-11 | Enright Patrick G | Sale | 10,000 | 176.31 | 1,763,050 |
2015-04-14 | Hooper Suzanne Sawochka (EVP & General Counsel) | Sale | 4,000 | 181.45 | 725,800 |
2015-04-14 | Cox Russell J. (EVP & COO) | Sale | 500 | 181.45 | 90,725 |
2015-04-14 | Cozadd Bruce C (Chairman & CEO) | Sale | 5,000 | 181.45 | 907,250 |
2015-04-06 | Enright Patrick G | Sale | 10,000 | 169.17 | 1,691,730 |
2015-03-25 | Mulligan Seamus (Director) | Sale | 50,000 | 176.22 | 8,810,750 |
2015-03-18 | Mulligan Seamus (Director) | Sale | 50,000 | 185.00 | 9,250,000 |
2015-03-10 | Hooper Suzanne Sawochka (EVP & General Counsel) | Sale | 1,851 | 170.36 | 315,336 |
2015-03-10 | Hooper Suzanne Sawochka (EVP & General Counsel) | Option Ex | 1,851 | 46.83 | 86,682 |
2015-03-10 | Cozadd Bruce C (Chairman & CEO) | Sale | 5,000 | 170.35 | 851,750 |
2015-03-05 | Cox Russell J. (EVP & COO) | Sale | 500 | 175.10 | 87,550 |
2015-03-04 | Wilson Karen J (SVP, Finance & PAO) | Option Ex | 5,159 | 37.15 | 191,631 |
2015-03-03 | Wilson Karen J (SVP, Finance & PAO) | Sale | 2,598 | 176.27 | 457,949 |
2015-03-02 | Enright Patrick G | Sale | 10,000 | 175.60 | 1,755,980 |
2015-02-10 | Hooper Suzanne Sawochka (EVP & General Counsel) | Sale | 1,851 | 166.90 | 308,931 |
2015-02-10 | Hooper Suzanne Sawochka (EVP & General Counsel) | Option Ex | 1,851 | 46.83 | 86,682 |
2015-02-10 | Tobias Jeffrey K (EVP, R&D & CMO) | Sale | 5,000 | 166.91 | 834,545 |
2015-02-10 | Tobias Jeffrey K (EVP, R&D & CMO) | Option Ex | 5,000 | 46.83 | 234,150 |
2015-02-10 | Enright Patrick G | Sale | 10,000 | 167.37 | 1,673,650 |
2015-02-10 | Cozadd Bruce C (Chairman & CEO) | Sale | 5,000 | 166.90 | 834,500 |
2015-01-13 | Hooper Suzanne Sawochka (EVP and General Counsel) | Sale | 1,851 | 161.73 | 299,362 |
2015-01-13 | Hooper Suzanne Sawochka (EVP and General Counsel) | Option Ex | 1,851 | 46.83 | 86,682 |
2015-01-13 | Cozadd Bruce C (Chairman and CEO) | Sale | 5,000 | 161.73 | 808,650 |
2015-01-05 | Enright Patrick G | Sale | 10,000 | 160.66 | 1,606,600 |
Insider trading activities including stock purchases, stock sales, and option exercises of JAZZ listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Jazz Pharmaceuticals Plc (symbol JAZZ, CIK number 1232524) see the Securities and Exchange Commission (SEC) website.